Building tomorrow's
breakthroughs
Panacea Venture is a healthcare venture fund with global vision and reach dedicated to transforming lives through promising innovation
About our
investment firm
Spun out from Kleiner Perkins China, the founding partners set up a new platform to leverage the sea change occurring in China, while establishing a global footprint to invest in innovation. To date, Panacea Venture raised three USD funds and an RMB fund from renowned institutional funds as well as strategic investors and has investments in more than 30 private companies and several public companies.
Portfolio
Panacea incubates early-stage companies with breakthrough technologies and discoveries that can potentially address unmet medical needs to enhance quality of life on a global scale.
.png)
Our approach
We build and capture value from company formation to expansion stage to public market investing.
35+
19+
Venture Partners
100+
Exciting Update! Explore Myrtelle’s Insightful Slide Presentation on Gene Therapy for Canavan Disease Preliminary One-Year Results from Meeting on the Mesa.
Here is the link to Alliance for Regenerative Medicine's Youtube Channel. Mark Hurtt gave a presentation last month at Mesa, here is the slideshow he presented with…
Exciting Update! Explore Myrtelle’s Insightful Slide Presentation on Gene Therapy for Canavan Disease Preliminary One-Year Results from Meeting on the Mesa.
Here is the link to Alliance for Regenerative Medicine's Youtube Channel. Mark Hurtt gave a presentation last month at Mesa, here is the slideshow he presented with…
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD)
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD)